Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Merck and GPHL Collaborate on Business Innovation and Development in the Greater Bay Area 2021-03-02 18:12
Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX® (Sumatriptan Nasal Spray, 20 mg) 2021-03-02 16:01
Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug 2021-03-02 15:21
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody 2021-03-02 13:43
Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB 2021-03-02 07:00
INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18 2021-03-02 05:05
New NCCN Guidelines for Histiocytosis Clarify Best Practices for Recently-Defined Cancers 2021-03-01 21:35
BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants 2021-03-01 21:00
China Biologic Announces Shareholders' Approval of Merger Agreement 2021-03-01 21:00
Frost & Sullivan Reveals Virtual Care's Enormous Potential in the United States 2021-03-01 20:02
Medilink Therapeutics Raises $50 Million in Series A Financing To Accelerate Next-Generation Conjugated Drugs Research & Development 2021-03-01 19:50
CARsgen Therapeutics Receives Orphan Medicinal Product Designation from the European Medicines Agency for CT041 CLDN18.2 CAR T Cells for the Treatment of Gastric Cancers 2021-03-01 19:00
Merck Builds on Leadership in Head and Neck Cancer Through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant 2021-03-01 18:48
TVM Capital Healthcare Exits Cambridge Medical and Rehabilitation Center for US$ 232 Million, a 4.6x Return on Capital Invested 2021-03-01 16:18
Avalon SteriTech and SoftBank Robotics Group Launch New Joint Venture to Develop and Promote Innovative Public Healthcare and Hygiene Solutions 2021-03-01 13:00
Everest Medicines Announces Selection as a Constituent of Certain Indexes of Hang Seng Indexes Company Limited 2021-03-01 12:36
Sciwind's Investigational New Drug Approved for NASH Trial 2021-03-01 09:00
Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody 2021-03-01 08:23
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
Antengene (6996.HK) Selected as a Constituent Stock of Nine Benchmark and Thematic Indexes Including the Hang Seng Composite Index 2021-03-01 08:00
1 556 557 558 559 560 1508